phv00122908.v1 ::: Meds: Acetaminophen 
phv00123181.v1 ::: 74 On average, how many tablets acetaminophen taken 
phv00086503.v2 ::: ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S 
phv00110634.v1 ::: Acetylcholine esterase inhibitors for Al 
phv00007292.v1 ::: BETA BLOCKER GROUP 
phv00105031.v1 ::: Beta-blockers with diuretics 
phv00086924.v2 ::: BETA-BLOCKERS WITH DIURETICS 
phv00053894.v2 ::: YEARS TAKING ALLOPURINOL (ALL PARTICIPANTS) 
phv00099575.v1 ::: Combinations of angiotensin II antagonists 
phv00086002.v2 ::: ACE INHIBITORS WITH DIURETICS 
phv00106435.v1 ::: ACE Inhibitors without diuretics 
phv00009191.v3 ::: RENIN-ANGIOTENSIN BLOCKING DRUGS 
phv00083093.v1 ::: ANTI-ARRHYTHMICS, CLASS 1C 
phv00103076.v1 ::: Anti-arrhythmics, class 1C 
phv00056974.v1 ::: Non-steroidal anti-inflammatory agents, excluding aspirin 
phv00107426.v1 ::: Tricyclic anti-depressants 
phv00173653.v1 ::: Antineoplastic agents that have been prescribed to the patient 
phv00127076.v1 ::: SFFQ: arginine (gm) 
phv00054305.v2 ::: OTHER REGULAR-STRENGTH ASPIRIN NAME (ALL PARTICIPANTS) 
phv00127944.v1 ::: 33: Now taking aspirin? 
phv00056788.v1 ::: Aspirin:  the last two weeks, did you take any aspirin or aspirin-containing medicines such as Bufferin, Anacin, or Ascriptin 
phv00034122.v1 ::: Average number of aspirin or other prostaglandin inhibitors - containing tablets per month 
phv00086003.v2 ::: ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) 
phv00006877.v1 ::: ASPIRIN: USUAL ASPIRIN DOSE 
phv00010183.v3 ::: ASPIRIN: USUAL ASPIRIN DOSE FOR ABOVE 
phv00015058.v1 ::: E6. Benzodiazepines Restoril, (Participants with European ancestry). DIGS3 
phv00127086.v1 ::: SFFQ: caffeine (mg) 
phv00095443.v1 ::: Caffeine (mg) 
phv00007288.v1 ::: CALCIUM CHANNEL BLOCKER GROUP 
phv00009178.v3 ::: CALCIUM CHANNEL BLOCKERS 
phv00106457.v1 ::: T-type calcium-channel blocker 
phv00086950.v2 ::: IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR 
phv00008780.v3 ::: CARDIAC GLYCOSIDES 
phv00008779.v3 ::: ANY CARDIOVASCULAR MEDICATIONS? 
phv00006466.v1 ::: CARDIOVASCULAR MEDICATIONS - BETA BLOCKERS (SPECIFY) 
phv00010176.v3 ::: CARDIOVASCULAR MEDICATIONS: ANTI-ARRHYTHMICS (QUINIDINE, PROCAINAMIDE, AMIODARONE, SOTALOL DISOPYRAMIDE, ETC.) 
phv00007287.v1 ::: CARDIOVASCULAR MEDICATIONS: CALCIUM CHANNEL BLOCKERS 
phv00010172.v3 ::: CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL) 
phv00010187.v3 ::: NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN) 
phv00173730.v1 ::: Cardiovascular agents that have been prescribed to the patient 
phv00007304.v1 ::: CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC) 
phv00006869.v1 ::: CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES 
phv00018477.v1 ::: J49. Cocaine.  (Participants with European ancestry). DIGS4 
phv00018401.v1 ::: J37. Cocaine.  (Participants with European ancestry). DIGS4 
phv00016040.v1 ::: J51. Cocaine High in Sch/Work, (Participants with European ancestry). DIGS3 
phv00065683.v1 ::: F3. Diabetes management: units Ultralente insulin used - other 
phv00048670.v1 ::: F3. Diabetes management: units NPH insulin used-supper 
phv00048962.v1 ::: F4. Diabetes management: total number of units/day of insulin 
phv00169156.v2 ::: Heroin Use 
phv00156479.v2 ::: Dietary Phenylalanine (g) 
phv00156483.v2 ::: Dietary Tryptophan (g) 
phv00108248.v1 ::: Immediate-release diltiazem 
phv00104462.v1 ::: Any diuretic 
phv00086931.v2 ::: ANY DIURETIC 
phv00095245.v1 ::: MEDICATION CODE NO. -- REPLACES Q7C 
phv00083806.v2 ::: NAME OF 3RD MEDICATION 
phv00095290.v1 ::: TAKE MEDICATION L IN PAST 24 HRS? Q15D 
phv00102833.v1 ::: STOP ANY MEDICATION IN PAST MONTH 
phv00095224.v1 ::: MEDICATION CODE NO. -- REPLACES Q04B 
phv00114475.v2 ::: MEDICATION NUMBER. Q 4.03A 
phv00095109.v1 ::: TAKE MEDICATION K IN PAST 24 HRS? Q14D 
phv00104463.v1 ::: Any lipid-lowering medication 
phv00105635.v1 ::: DAYS TOOK THIS MEDICINE IN LAST TWO WEEK 
phv00118693.v2 ::: MEDICATION NUMBER: HORMONE MED 
phv00108767.v1 ::: STOP ANY MEDICATION IN PAST MONTH 
phv00065927.v1 ::: P12a. Medication, grade of right femoral pulse 
phv00015714.v1 ::: I 30. ETOH+Drugs Dangerous Mix, (Participants with European ancestry). DIGS3 
phv00108147.v1 ::: NAME OF FIRST MEDICATION CHANGED 
phv00158561.v1 ::: Medication ongoing - coded fields 
phv00053417.v1 ::: B6 Medication (row 25), (African American participants). DIGS4 
phv00019156.v1 ::: Q11.  Use of pills, drugs.  (Participants with European ancestry). DIGS4 
phv00095158.v1 ::: MEDICATION CODE (AHF CODE) - Q11B 
phv00095055.v1 ::: MEDICATION CODE (AHF CODE) - Q11B 
phv00007352.v1 ::: NONCARDIOVASCULAR MEDICATIONS: OSTEOPOROSIS MEDICATIONS 
phv00079032.v3 ::: Take medication for sleep 
phv00005618.v1 ::: MEDICATION USE: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.) 
phv00095001.v1 ::: GET MEDICATIONS INFO LATER?       Q3 
phv00102090.v1 ::: TAKE ANY MEDICATIONS 
phv00087382.v1 ::: TOTAL MEDICATIONS 
phv00011963.v1 ::: E4. Have you ever taken medications for your nerves or any emotional or mental problems? Antidepressants: Wellbutrin. (Participants with European ancestry). DIGS2 
phv00011965.v1 ::: E4. Have you ever taken medications for your nerves or any emotional or mental problems? MAOI's:  Marplan. (Participants with European ancestry). DIGS2 
phv00066848.v5 ::: Description/Label for chemical subgroup - fourth drug in compound 
phv00012668.v1 ::: J22. Did you ever need larger amounts of (drug) to get an effect, or find that you could no longer get high on the amount you used to use? INTERVIEWER: code YES if at least 50% more use. C SED. (Participants with European ancestry). DIGS2 
phv00012775.v1 ::: J32a. While using (drug), did you ever have any psychological problems start or get worse, such as feeling depressed, feeling paranoid, trouble thinking clearly, hearing, smelling, or seeing things, or feeling jumpy? IF YES:) Specify which problems, read appropriate sub questions to confirm response and code. Specify. (Participants with European ancestry). DIGS2 
phv00012741.v1 ::: J28. Did using (drug) cause you to have any other physical health problems (other than withdrawal)? B STIM. (Participants with European ancestry). DIGS2 
phv00011723.v1 ::: B5. If yes to B5, specify medication, dosage and duration (Med 4 R's response). (Participants with European ancestry). DIGS2 
phv00169349.v1 ::: Emphysema: received medical treatment or used medications/inhaler 
phv00107253.v1 ::: TOOK ESTROGEN IN THE PAST 
phv00108754.v1 ::: SPECIFY OTHER REASONS FOR TAKING ESTROGEN 
phv00108114.v1 ::: DAYS PER MONTH TAKE ESTROGEN 
phv00109716.v1 ::: Estrogens,  excluding vaginal creams 
phv00104934.v1 ::: YEAR STOPPED TAKING ESTROGEN 
phv00079644.v3 ::: Estrogen pill past year 
phv00108124.v1 ::: DAYS PER MONTH TOOK ESTROGEN 
phv00108130.v1 ::: TOOK ESTROGEN TO PREVENT OTHER SYMPTOMS 
phv00078016.v3 ::: Did you use an estrogen patch? 
phv00089316.v1 ::: Estrogen - Exam 18 
phv00077852.v3 ::: Estrogen pill dose per day 
phv00078020.v3 ::: Estrogen shots 
phv00077854.v3 ::: Months took estrogen shots 
phv00065866.v1 ::: O6a. Female/reproductive: now uses oral contraceptives 
phv00006929.v1 ::: FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PROGESTIN 
phv00007363.v1 ::: FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN 
phv00158213.v1 ::: FFQ: TAKE IODINE SUPPLEMENT 
phv00157390.v1 ::: FFQ: MULTIVITAMINS BRAND 
phv00069876.v2 ::: FFQ: TAKE ZINC SUPPLEMENT 
phv00053892.v2 ::: YEARS TAKING NITROGLYCERIN (ALL PARTICIPANTS) 
phv00126671.v1 ::: SFFQ: glycine (gm) 
phv00026199.v1 ::: MDI - prescribed change in insulin regimen because of: symptoms of polyuria, polydipsia 
phv00165310.v2 ::: BASELINE INSULIN RIA METHOD 
phv00025787.v1 ::: Describe insulin regimen (if different from that described in Question 4) 
phv00029229.v1 ::: Change insulin regimen to: units of NPH or lente insulin 
phv00122931.v1 ::: Meds: Insulin 
phv00031671.v1 ::: Patient's performance rating: task 1 - draw 9 U of insulin in 0.5cc syringe, trial 2 
phv00029812.v1 ::: MDI4  - previous day: units of regular or semi-lente insulin 
phv00029810.v1 ::: MDI4  - previous day: units of long-acting or ultra-lente insulin 
phv00050802.v1 ::: B5g. Does your health insurance provide coverage for: glucose tablets 
phv00161755.v1 ::: Isoleucine 
phv00007731.v3 ::: MENOPAUSE: EVER TAKEN PREMARIN 
phv00166791.v2 ::: Methionine 
phv00086053.v2 ::: IMMEDIATE-RELEASE NIFEDIPINE 
phv00123789.v1 ::: Nitric Oxide: Ambient Air 
phv00126381.v1 ::: LFFQ: MUFA 18:1 (oleic acid) (gm) 
phv00018414.v1 ::: J39. Opiates.  (Participants with European ancestry). DIGS4 
phv00018419.v1 ::: J40. Opiates.  (Participants with European ancestry). DIGS4 
phv00018409.v1 ::: J38. Opiates.  (Participants with European ancestry). DIGS4 
phv00052792.v1 ::: J47 Opiates, (African American participants). DIGS4 
phv00052746.v1 ::: J39 Opiates, (African American participants). DIGS4 
phv00109022.v1 ::: Slow-release nifedipine 
phv00087377.v1 ::: SLOW-RELEASE VERAPAMIL 
phv00107434.v1 ::: Slow-release verapamil 
phv00166859.v2 ::: Phosphatidylcholine (carbon:double bond = 36:3) 
phv00071067.v2 ::: Number of months from Baseline to first prednisone burst.  This is calculated by dividing the number of days between Baseline and the first prednisone burst by 30.25. 
phv00109746.v1 ::: Probucol 
phv00085385.v2 ::: PROGESTINS 
phv00056983.v1 ::: Progestins 
phv00106334.v1 ::: YEARS TOOK PROGESTIN IN PAST 
phv00108755.v1 ::: CURRENTLY TAKING PROGESTIN 
phv00077669.v3 ::: Progesterone use last 2 years 
phv00126541.v1 ::: RECALL: aspartame 
phv00126897.v1 ::: RECALL: calcium 
phv00126526.v1 ::: RECALL: leucine 
phv00126973.v1 ::: RECALL: vitamin E (International Units) 
phv00126893.v1 ::: RECALL: pantothenic acid 
phv00126966.v1 ::: RECALL: synthetic folate 
phv00052801.v1 ::: J48 Sedatives, (African American participants). DIGS4 
phv00052811.v1 ::: J49 Sedatives, (African American participants). DIGS4 
phv00168306.v1 ::: Prior to your recent stroke, did you ever regularly take multi-vitamins?  (DSF)  Aside from the VISP vitamin, have you regularly taken multi-vitamins during the past year? (FDS) 
phv00083148.v1 ::: SYMPATHOMIMETICS, ORAL AND INHALED 
phv00087368.v1 ::: SYMPATHOMIMETICS, ORAL AND INHALED 
phv00066841.v5 ::: Description/Label for therapeutic subgroup - third drug in compound 
phv00126395.v1 ::: LFFQ: threonine (gm) 
phv00072913.v1 ::: Tsh (Thyroid stimulating hormone) - Milli-International-Units (MIU) 
phv00053882.v2 ::: YEARS TAKING TRIAMTERENE (ALL PARTICIPANTS) 
phv00161764.v1 ::: Tyrosine 
phv00166798.v2 ::: Valine 
phv00098253.v1 ::: VIT E:UNITS                         Q5E 
phv00098385.v1 ::: Vitamin E without vitamin pills mg 
phv00119328.v2 ::: FREQ (DAY/WEEK/MONTH) TAKEN (ZINC). Q 4 
phv00098302.v1 ::: ZINC :DOSE PER PILL                 QDE 
phv00086941.v2 ::: AMLODIPINE 
phv00085335.v2 ::: AMLODIPINE 
phv00105021.v1 ::: Amlodipine 
phv00156518.v2 ::: Dietary Biochanin A (mg) 
phv00124520.v1 ::: Time to start of paroxetine 
phv00090842.v1 ::: Rifaximin (Xifaxan) 
phv00126680.v1 ::: SFFQ: sucrose polyester (gm) 
phv00120353.v2 ::: NUMBER TAKEN (VITAMIN A). Q 2 
phv00029072.v1 ::: Standard treatment  - previous day: type of insulin - pork 
phv00050038.v1 ::: D4a. Treatment of clinical manifestation: given intravenous glucose treatment 
phv00126239.v1 ::: PUFA 18:3 (linolenic acid) (g) 
phv00015028.v1 ::: E6. Serotonin specific reuptke inhibitors (SSRIs. Celexa, (Participants with European ancestry). DIGS3 
phv00005584.v1 ::: MEDICATION USE: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL) 
phv00004999.v1 ::: MEDICATION USE: ANTICONVULSANTS (DILANTIN, PHENOBARB, TEGRETOL, MYSOLINE, ETC.) 
phv00004981.v1 ::: MEDICATION USE: INSULIN 
phv00006150.v1 ::: MEDICATION USE - THYROID EXTRACT (DESSICATED THYROID) 
phv00004992.v1 ::: MEDICATION USE: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H-ION INHIBITORS) 
phv00109004.v1 ::: Erectile dysfunction drugs 
phv00016038.v1 ::: J50. Opioids Despite Objection, (Participants with European ancestry). DIGS3 
phv00086965.v2 ::: ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) 
phv00015111.v1 ::: E6. Antimaniac agents Oth Antimanic Agt 1 Spec, (Participants with European ancestry). DIGS3 
phv00001251.v1 ::: INTERIM HISTORY OF MEDICINE:  ANTIBACTERIAL 
phv00000954.v1 ::: INTERIM HISTORY OF DRUGS TAKEN: HYPOCHOLESTEROL, EXAM 7 
phv00002220.v1 ::: INTERIM HISTORY OF MEDICINE USED: NITRITES 
phv00001820.v1 ::: INTERIM HISTORY OF MEDICINE USED: NITRITES 
phv00002951.v1 ::: INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES 
phv00001445.v1 ::: INTERIM HISTORY OF MEDICINE USED: HYPOGLYCEMIC AGENTS 
phv00056994.v1 ::: Thyroid agents 
phv00112705.v2 ::: IRON (MG) 
phv00008106.v3 ::: IRON 
phv00079522.v3 ::: Supplemental Potassium, mg 
phv00163806.v2 ::: Was the Patient Exposed to Hydroxyurea Prior to Procurement? 
phv00055358.v2 ::: Loop diuretics 
phv00107435.v1 ::: Oral anticoagulants 
phv00007335.v1 ::: ORAL HYPOGLYCEMICS: UNKNOWN 
phv00004621.v1 ::: ORAL HYPOGLYCEMICS 
phv00077725.v3 ::: Natural/Progest suppositories 
phv00014755.v1 ::: B 5. Medication Weeks - 3, (Participants with European ancestry). DIGS3 
phv00158562.v1 ::: Medication start period is estimated - coded fields 
phv00086027.v2 ::: ANTI-PSYCHOTIC MEDICATIONS 
